Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert Keenan, MD
Arthrosi Therapeutics, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arthrosi Investigative Site (105)
Margate, Florida, United States
- Arthrosi Investigative Site (102)
Miami, Florida, United States
- Arthrosi Investigative Site (109)
Tampa, Florida, United States
- Arthrosi Investigative Site (106)
Jackson, Mississippi, United States
- Arthrosi Investigative Site (108)
Charlotte, North Carolina, United States
- Arthrosi Investigative Site (103)
Duncansville, Pennsylvania, United States
- Arthrosi Investigative Site (104)
West Lake Hills, Texas, United States
- Arthrosi Investigative Site (107)
Bellevue, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Dec 2025
- Primary completion
- 30 Nov 2026
- Completion
- 28 Feb 2027
- Last update posted
- 15 May 2026
- Registered enrollment
- 15
- Registry id
- NCT07116746
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.